Gut microbiome and PCOS: Nature Reviews Endocrinology meta-analysis of 34 studies
Source: Nature Reviews Endocrinology, April 25, 2026
Summary
A systematic review and meta-analysis published in Nature Reviews Endocrinology (April 2026) synthesizes 34 studies on the gut microbiome in PCOS. Key findings: significant reduction in Lactobacillaceae and Bifidobacterium in women with PCOS vs controls (moderate effect, SMD -0.62, 95%CI -0.84 to -0.40). Increased pro-inflammatory Firmicutes. These alterations correlate with insulin resistance severity (r=0.48) and androgen levels (r=0.39). The authors propose a gut-ovarian axis mechanism: (1) increased intestinal permeability leading to endotoxemia, systemic inflammation, insulin resistance, and hyperandrogenism; (2) altered bile acid metabolism affecting nuclear receptor signaling. Promising interventions: prebiotic fibers (inulin, FOS), targeted probiotics (Lactobacillus reuteri + Bifidobacterium longum), Mediterranean diet. Limitations: heterogeneity in sequencing methods, possible reverse causation. Conclusion: gut microbiome is not proven to cause PCOS but represents a compelling complementary therapeutic target.
Why it matters for you
You don't need expensive probiotics right away — but this robust meta-analysis justifies attention to your diet: prebiotic fibers (legumes, leeks, garlic), fermented foods (yogurt, kefir), and reducing refined sugars are accessible levers that support your microbiome without risk and have other metabolic benefits for PCOS.